Comparison of Best Medical Treatment Versus Best Medical Treatment Plus Renal Artery Stenting
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The clinical investigation is a prospective, international, multi-centre, randomized (1:1)
trial with follow ups at 2, 6, 12 months and 3 years.
The purpose of the study is to evaluate the clinical impact of percutaneous transluminal
renal artery stenting (PTRAS) on the impaired renal function measured by the estimated
Glomerular Filtration Rate (eGFR) in patients with hemodynamically significant
atherosclerotic renal artery stenosis (ARAS).